Announced Mon, 6 Jul · 10:47 IST
Board to appoint new MD after demise of Umesh B. Sandu
Management Changes View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.3%1-day move
₹41.60
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-0.3-0.4-2.5-1.4-1.6-1.4-5.5———
Up moveDown movePending
AI summary
Sandu Pharmaceuticals board will meet on 11 July 2026 to record the demise of Managing Director Umesh B. Sandu, who passed away on 19 June 2026. The board will consider appointing a new Managing Director and an additional Independent Director, and reconstitute board committees. Trading window is closed from 1 July 2026 until 48 hours after Q1 results are announced.
Likely market impact
Leadership transition at the top due to MD demise may cause short-term uncertainty, but board appears prepared with succession steps.